Algert Global buys $3,161,129 stake in Masimo Corporation (MASI)

Masimo Corporation (MASI) : Algert Global scooped up 19,813 additional shares in Masimo Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 53,889 shares of Masimo Corporation which is valued at $3,161,129.Masimo Corporation makes up approximately 0.93% of Algert Global’s portfolio.

Other Hedge Funds, Including , Legal General Group Plc boosted its stake in MASI in the latest quarter, The investment management firm added 29,821 additional shares and now holds a total of 40,394 shares of Masimo Corporation which is valued at $2,369,512.Simplex Trading boosted its stake in MASI in the latest quarter, The investment management firm added 201 additional shares and now holds a total of 292 shares of Masimo Corporation which is valued at $17,511.Independent Portfolio Consultants reduced its stake in MASI by selling 160 shares or 1.27% in the most recent quarter. The Hedge Fund company now holds 12,410 shares of MASI which is valued at $740,505. Masimo Corporation makes up approx 0.23% of Independent Portfolio Consultants’s portfolio.Eqis Capital Management reduced its stake in MASI by selling 555 shares or 7.92% in the most recent quarter. The Hedge Fund company now holds 6,457 shares of MASI which is valued at $385,289. Masimo Corporation makes up approx 0.02% of Eqis Capital Management’s portfolio.

Masimo Corporation closed down -1.7 points or -2.82% at $58.66 with 2,94,002 shares getting traded on Tuesday. Post opening the session at $60.27, the shares hit an intraday low of $58.295 and an intraday high of $60.27 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Masimo Corporation reported $0.57 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.41. The company had revenue of $172.64 million for the quarter, compared to analysts expectations of $166.03 million. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

Many Wall Street Analysts have commented on Masimo Corporation. Company shares were Reiterated by Wedbush on Aug 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 63 from a previous price target of $60 .

Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Leave a Reply

Masimo Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Masimo Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.